Literature DB >> 25331819

Clinical implications of recent exodontia before diagnosis of gingival squamous cell carcinoma: A new classification.

Chi-Sheng Cheng1, Chien-Ming Chang1, Ying-Lyung Hsiao1, Man-Yee Chan2,3, Chun-Yin Lee1, Li-Tzu Lee1, Yong-Kie Wong2,4.   

Abstract

BACKGROUND: The purpose of this study was to clarify the clinical implications of cases with recent dental extractions to establish a new classification of gingival squamous cell carcinoma (SCC).
METHODS: A total of 156 patients were enrolled in this study. The subjects were divided into 3 groups: type I (dentate; n = 46), type II (edentulous; n = 55), and type III (dental extraction; n = 55). Continuous clinical and treatment variables were analyzed by 1-way analysis of variance (ANOVA) or t test, and categorical variables were evaluated by chi-square tests. Assessment of 5-year survival rates were carried out by the Kaplan-Meier analysis, and the influence of related factors was evaluated by the log-rank test. RESULT: The 55 type III patients showed a high probability of bony invasion (80%) and a lower 5-year survival rate (48%) than the other 2 groups.
CONCLUSION: Our proposed classification may help clinicians to identify patients with gingival SCC who present with more advanced disease status.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  asymptomatic clinical features; classification; dental extraction; mechanism of bone invasion; squamous cell carcinoma (SCC)

Mesh:

Year:  2015        PMID: 25331819     DOI: 10.1002/hed.23896

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  1 in total

1.  Prognostic and staging implications of mandibular canal invasion in lower gingival squamous cell carcinoma.

Authors:  Masaya Okura; Souichi Yanamoto; Masahiro Umeda; Mitsunobu Otsuru; Yoshihide Ota; Hiroshi Kurita; Takahiro Kamata; Tadaaki Kirita; Nobuhiro Yamakawa; Tetsuro Yamashita; Michihiro Ueda; Takahide Komori; Takumi Hasegawa; Tomonao Aikawa
Journal:  Cancer Med       Date:  2016-10-19       Impact factor: 4.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.